Microba Life Sciences Ltd has released a press release.
Appendix 4D & FY25 Interim Report
Filed with ASX ·
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call6ix hasn’t read this filing yet.
Microba Life Sciences Limited on 6ix
Story so far
Earlier from Microba Life Sciences
- Q2 FY25 Quarterly Investor Presentation & Webinar
- Q2 FY25 Quarterly Activities Report & Appendix 4C
- Trading Update
- Microba receives $6 million R&D Tax Incentive Refund
- Q1 FY25 Quarterly Investor Presentation
Later from Microba Life Sciences
- Microba Delivers Landmark IBD Results & Signs Major Gastro Partner
- Q3 FY25 Quarterly Activities Report & Appendix 4C
- Q3 FY25 Quarterly Investor Presentation & Webinar
- Landmark GI Study Results from over 4,600 patients
- Microba Announces Landmark GI Study Results From Over 4,600 Patients
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences